Spire Healthcare Group plc (SPI)

London
230.62
-4.50(-1.92%)
  • Volume:
    39,104
  • Bid/Ask:
    230.00/231.00
  • Day's Range:
    230.00 - 235.50

SPI Overview

Prev. Close
234.5
Day's Range
230-235.5
Revenue
1.21B
Open
235.5
52 wk Range
201-256.5
EPS
0.017
Volume
39,104
Market Cap
931.21M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
401,139
P/E Ratio
133.82
Beta
1.33
1-Year Change
-2.9%
Shares Outstanding
403,784,558
Next Earnings Date
02 Mar 2023
What is your sentiment on Spire Healthcare?
or
Vote to see community's results!

Spire Healthcare Group plc News

Spire Healthcare Group plc Analysis

Spire Healthcare Group plc Company Profile

Spire Healthcare Group plc Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Read More

Analyst Price Target

Average293.71 (+27.36% Upside)
High341
Low240
Price230.62
No. of Analysts7
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyBuy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy
  • they started to cut costs down in preparation for a takeover. potential investors are eyeing profits from rise in private treatments due to huge post COVID backlog of cases.
    0
    • Why is it rising so much??
      0